Cubist Systematic Strategies’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Cubist Systematic Strategies’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,042	Closed	-$58K	–	2383
2018 Q3	$58K	Sell	1,042 -735	-41%	-$46.9K	﹤0.01%	1691
2018 Q2	$127K	Buy	1,777 +1,242	+232%	+$87.7K	0.01%	1471
2018 Q1	$33K	Buy	+535	New	+$47K	﹤0.01%	1726
2017 Q4	–	Sell	-1,427	Closed	-$195K	–	2190
2017 Q3	$195K	Buy	+1,427	New	+$191K	0.01%	1460
2015 Q3	–	Sell	-575	Closed	-$545K	–	2093
2015 Q2	$545K	Buy	575 +55	+11%	+$45K	0.03%	912
2015 Q1	$381K	Buy	+520	New	+$391K	0.02%	1112

Other funds holding TTPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cubist Systematic Strategies's TTPH Position: Q4 2018 in Review

Cubist Systematic Strategies sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2018, closing a stake of 1,042 shares — an estimated $58K sold.

Cubist Systematic Strategies first reported a position in TTPH in Q1 2015 and held it in 6 quarters. The position peaked at $545K in Q2 2015. 86 funds tracked by Wall St. Rank hold TTPH as of Q4 2018.

Cubist Systematic Strategies reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Cubist Systematic Strategies sold 1,042 Tetraphase Pharmaceuticals, Inc. shares in Q4 2018, an estimated $58K.
Cubist Systematic Strategies first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 6 quarters.
Cubist Systematic Strategies's Tetraphase Pharmaceuticals, Inc. position peaked at $545K in Q2 2015.
86 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2018.

Based on Cubist Systematic Strategies's 13F filing for Q4 2018, filed 14 Feb 2019.